Literature DB >> 8181070

Bcl-2 expression in the thymus and periphery.

Y Fujii1, M Okumura, Y Takeuchi, K Inada, K Nakahara, H Matsuda, Y Tsujimoto.   

Abstract

Bcl-2 proto-oncogene is expressed in normal lymphoid tissues and its role has been suggested to involve the selection of B and T cells. Here we report three-color flow cytometric studies on the expression of bcl-2 protein in the thymus and periphery. Bcl-2 was expressed in the majority of T and B cells and down-regulated only in the CD1+, CD3- to low, CD4+8+ thymocytes, and the B cells that are in cell cycle in the tonsil and lymph node. In contrast, the CD2+, CD1-3-4-8-19-, early T cells, and mature single positive cells in the thymus, as well as the tonsilar and lymph node T cells, irrespective of their cell cycle status, expressed bcl-2. These results are consistent with the notion that bcl-2 is down-regulated in the T and B cells that are in the process of generating new antigen receptors and subject to subsequent positive selection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181070     DOI: 10.1006/cimm.1994.1127

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Signal transducer and activator of transcription 3 (Stat3) contributes to T-cell homeostasis by regulating pro-survival Bcl-2 family genes.

Authors:  Jin-Ku Lee; Cheolhee Won; Eun Hee Yi; Seung-Hyeok Seok; Myoung-Hwan Kim; Sang-Jeong Kim; Myung-Hee Chung; Hyun Gyu Lee; Koichi Ikuta; Sang-Kyu Ye
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

2.  Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.

Authors:  N Sharfe; H K Dadi; M Shahar; C M Roifman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.